Table 1 Baseline characteristics of the patients with USCP
From: Undifferentiated sarcomatoid carcinoma of the pancreas-a single-institution experience with 23 cases
Variables | No. of patients |
|---|---|
Age, median (range), y | 61.52 ± 13.01 (35–89) |
Sex, male, n (%) | 12 (52.2) |
Symptoms, n (%) | 18 (78.3) |
Abdominal pain/discomfort, n (%) | 16 (88.9) |
Nausea/vomiting, n (%) | 2 (11.1) |
Weight loss, n (%) | 4 (22.2) |
Loss of appetite/anorexia, n (%) | 4 (22.2) |
Fatigue, n (%) | 1 (5.6) |
Fever of unknown origin, n (%) | 2 (11.1) |
Palpable abdominal mass, n (%) | 4 (22.2) |
Preoperative jaundice, n (%) | 7 (30.4) |
Abnormal of tumor marker, n (%) | |
CEA | 12 (52.2) |
CA19-9 | 18 (78.3) |
CA125 | 8 (34.8) |
Location of tumor, n (%) | |
Head | 9 (39.1) |
Body and tail | 14 (60.9) |
Tumor size, median (range), mm | 62.5 (26–240) |
Radiological findings of the tumor, n (%) | |
Heterogeneous (cystic tumor combined solid component) | 4 (17.4) |
Cystic tumor | 0 |
Solid tumor | 19 (82.6) |
Heterogenous enhancement | 18 (78.3) |
Tumor density | |
Hypodense | 23 (100) |
Hyperdense | 0 |
Treatment, n (%) | |
TMpE Pancreaticoduodenectomy | 9 (39.1) |
DPS | 11 (47.8) |
TPS | 3 (13.0) |